Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...
Insider Monkey on MSN1d
Is Bristol-Myers Squibb Company (BMY) the Best Dividend Stock to Buy According to Billionaires?We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to ...
Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - ...
6don MSN
We recently published a list of Dividend Stock Portfolio For Income: Top 10 Stocks to Buy. In this article, we are going to ...
We recently compiled a list of the 15 Best S&P 500 Dividend Stocks to Buy Now. In this article, we are going to take a look ...
Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings ... Earlier this morning, we posted our quarterly slide presentation to bms.com that you can use to follow along with Chris and ...
Bristol-Myers Squibb Company (NYSE:BMY ... Earlier this morning, we posted our quarterly slide presentation to bms.com that you can use to follow along with Chris and David's remarks.
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best wide moat stocks to invest in. Russell Investments continues to monitor and ...
Bernstein analyst Courtney Breen maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) yesterday and set a price target of $62.00. The company’s shares closed yesterday at ...
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s shares closed yesterday at $54.98. See what stocks ...
Sandra Leung, one of the longest-serving legal chiefs in the pharmaceutical industry, plans to retire from Bristol Myers Squibb in 2025 after nearly 33 years with the company. Leung will be ...
Bristol-Myers Squibb stock opened at $59.15 on Wednesday. The company has a quick ratio of 1.09, a current ratio of 1.24 and a debt-to-equity ratio of 2.83. Bristol-Myers Squibb has a 52 week low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results